Why the study?
Hypertension is the most common chronic disease globally, but its precise cause often cannot be determined, leaving unmet needs for models that mimic discrete clinical hypertensive syndromes and aid in prevention and treatment.
This AHA scientific statement outlines the current utility, validity, and future needs for animal models in hypertension research.
Reinforces animal models as key tools in hypertension research; extends guidance by prioritizing syndrome-specific models for translational relevance.
Hypertension is the most common chronic disease in the world, yet the precise cause of elevated blood pressure often cannot be determined. Animal models have been useful for unraveling the pathogenesis of hypertension and for testing novel therapeutic strategies. The utility of animal models for improving the understanding of the pathogenesis, prevention, and treatment of hypertension and its comorbidities depends on their validity for representing human forms of hypertension, including responses to therapy, and on the quality of studies in those models (such as reproducibility and experimental design). Important unmet needs in this field include the development of models that mimic the discrete hypertensive syndromes that now populate the clinic, resolution of ongoing controversies in the pathogenesis of hypertension, and the development of new avenues for preventing and treating hypertension and its complications. Animal models may indeed be useful for addressing these unmet needs.
No takes yet. Share an insight, caveat, or question.
Lerman et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: